Palvella Therapeutics (PVLA) Return on Invested Capital (2014 - 2019)
Palvella Therapeutics (PVLA) reported Return on Invested Capital of 0.02% for Q3 2019, down 2.0% year-over-year from 0.02% in Q3 2018, and down 9.73% on a QoQ basis from 0.02% in Q2 2019.
Palvella Therapeutics (PVLA) has 6 years of Return on Invested Capital data on file, last reported at 0.02% in Q3 2019.
- Quarterly Return on Invested Capital fell 2.0% year-over-year to 0.02% in Q3 2019, while the trailing twelve-month figure through Sep 2019 was 0.02% (down 2.0% YoY) and the FY2020 annual result came in at 0.01%, changed N/A from the prior year.
- Return on Invested Capital fell to 0.02% in Q3 2019 per PVLA's latest filing, from 0.02% in the prior quarter.
- Across five years, Return on Invested Capital topped out at 0.0% in Q2 2018 and bottomed at 0.04% in Q3 2017.
- The 5-year median for Return on Invested Capital is 0.01% (2018), against an average of 0.01%.
- The widest annual swing landed in 2015, when Return on Invested Capital jumped 1207 bps; it then slipped 2 bps in 2017.
- Tracing PVLA's Return on Invested Capital over 5 years: stood at 0.0% in 2015, then slipped by 22 bps to 0.01% in 2016, then sank by 271 bps to 0.02% in 2017, then surged by 65 bps to 0.01% in 2018, then tumbled by 183 bps to 0.02% in 2019.
- Per Business Quant, the three latest PVLA Return on Invested Capital figures stand at 0.02% (Q3 2019), 0.02% (Q2 2019), and 0.01% (Q1 2019).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -0.01% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 0.00% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -0.01% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.00% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 0.01% |
| 10 | Palvella Therapeutics | 1.47 Bn | 1.21 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | -0.02% |
| Jun 30, 2019 | -0.02% |
| Mar 31, 2019 | -0.01% |
| Dec 31, 2018 | -0.01% |
| Sep 30, 2018 | 0.00% |
| Jun 30, 2018 | 0.00% |
| Mar 31, 2018 | -0.01% |
| Dec 31, 2017 | -0.02% |
| Sep 30, 2017 | -0.04% |
| Jun 30, 2017 | -0.02% |
| Mar 31, 2017 | -0.01% |
| Jun 30, 2016 | -0.01% |
| Mar 31, 2016 | 0.00% |
| Dec 31, 2015 | 0.00% |
| Sep 30, 2015 | -0.01% |
| Jun 30, 2015 | -0.01% |
| Mar 31, 2015 | -0.01% |
| Sep 30, 2014 | -8.09% |
| Jun 30, 2014 | -12.08% |
| Mar 31, 2014 | -0.02% |